Cheaper Cancer Drugs vs Patents: Will Delhi HC’s Zydus Ruling Expand Access To Treatment?

The Delhi HC ruling does not abolish patents or endorse blanket early entry. Instead, it stresses courts may intervene ...

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Where the product in question is a life-saving drug, the Court has to err in favour of public interest', said the bench ...

Hundreds without power in Suisun City area Monday afternoon

Hundreds of PG&E customers in the Suisun City area are without power Monday afternoon, according to the utility company’s ...

Avinasi Labs Brings Disease-Specific Data Lakes On-Chain via DeLong Protocol, Through Collaboration with ECODI Meditech

SAN FRANCISCO, CA, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Avinasi Labs, an AI-native longevity infrastructure company building the world’s first liquid foundation model for ageing ...
pv magazine International

AlphaESS launches modular energy storage system for small C&I users

Designed for power ratings of 29.9 kW and 50 kW with scalable capacity up to 216,9 kWh, the new system is aimed at businesses seeking flexible energy storage solutions without the complexity of instal ...

Delhi HC allows Zydus to sell, mkt generic version of cancer drug nivolumab

The Delhi High Court has allowed Zydus Lifesciences to sell its nivolumab biosimilar, citing public interest, while directing ...
The Joplin Globe

Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructi…

Bristol Myers Squibb (NYSE: BMY) today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos ...